C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides

Slides:



Advertisements
Similar presentations
Clinical Trial Results. org ABSORB Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Patrick W. Serruys.
Advertisements

Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
Can we prevent stent restenosis after coronary stent implantation
ARTS I & II Keith D Dawkins Southampton University Hospital.
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
Basel Stent Cost-effectiveness Trial-Late Thrombotic Events (BASKET LATE) Trial Basel Stent Cost-effectiveness Trial-Late Thrombotic Events (BASKET LATE)
Call for CASES One Stage Coronary And Peripheral Intervention (OCAPI) in a patient with accelerated diffuse atherosclerosis after chest irradiation. One.
M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
5F in 6F (7F) technique in DES era (Parent-child catheter technique)
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons Presented at The American Heart Association Scientific Session 2006 Presented by Dr.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
TAXUS ATLAS Trial Presented at The EuroPCR meeting Paris, France May 2006 Presented by Dr. Mark Turco TAXUS ATLAS 9-Month Results: Evaluation of TAXUS.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
Basel Stent Cost-Effectiveness (BASKET) Trial BASKET Trial Presented at The European Society of Cardiology Hotline Session 2005 Presented by Dr. Matthias.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Paclitaxel Eluting Stent Versus Conventional Stent in ST-segment Elevation Myocardial Infarction (PASSION) Trial Presented at The American College of Cardiology.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,
Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Clinical Experience with the Bio Active Stent (BAS) in FINLAND 9 e CFCI Hotel Meridien Etoile Paris, France 10 Octobre 2007 Pasi Karjalainen, MD, PhD.
The First Affiliated Hospital of Harbin Medical University
Using a deflectable tipped Catheter to treat previously inaccessible lesions Helen Routledge Interventional Fellow Institut Cardiovasculaire Paris Sud.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
A Prospective, Randomized Trial of a Paclitaxel coated Balloon vs. uncoated Balloon Angioplasty in Patients with Drug- Eluting Stent Restenosis PEPCAD-DES.
J Am Coll Cardiol 2008;51:538–45 Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization Pawel E. Buszman,
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Results From the MISSION! Intervention Study Sirolimus-Eluting Stents Vs Bare-Metal Stents in Patients With STEMI : 9-Month Angiographic and Intravascular.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at The American College.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
ISCHEMIC HEART DISEASE
Adel Gamal, MD and Mohamed Saber, Msc
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Clinical Presentation
Strategy planning in coronary bifurcation stenting
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Meruzhan Saghatelyan, MD, Interventional cardiologist
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,
Fractional Flow Reserve Workshop
Spontaneous Coronary Artery Dissection: Good Long-term Outcome with IVUS-Guided Diagnosis and Management Italo Porto Interventional Cardiology Unit Università.
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Using Coronary CTA to Guide Intervention for CTO
Section 5: Intervention and drug therapy
Giuseppe Biondi Zoccai, MD
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Presented at TCT 2006.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
DISTAL CORONARY ARTERY DISEASE
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
DISTAL CORONARY ARTERY DISEASE
Presentation transcript:

C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica – Kyanous Stavros, Thessaloniki. AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens

Criteria for case selection: DES Restenosis - Stent Fracture IVUS Venture catheter Rotablator Bifurcation Dissection

CASE REPORT 73 y.o. female patient, presenting with crescendo angina. Risk factors for IHD: Dyslipidaemia Hypertension No other significant past medical history Physical examination unremarkable Normal ECG

2007 Significant proximal LAD disease Taxus 2.75x32mm

5/2009: recurrent angina of recent onset progression of the disease with severe lesion in the mid segment of the LAD and no restenosis in the previously implanted stent.

5/2009: PCI - LAD PROMUS 2.5x28mm “Jailed” guidewire in D1 Postdilatation

5/2009: PCI - LAD FINAL RESULT Stent length 46mm

5/2009 Severe lesion in the intermediate branch and the circumflex artery.

5/2009: PCI-INTERMEDIATE BRANCH Promus 2.5x12mm DISSECTION !!!!

5/2009: PCI-INTERMEDIATE BRANCH RESIDUAL DISSECTION Promus 2.25x15mm

5/2009: PCI-INTERMEDIATE BRANCH Promus 2.25x15mm

5/2009: PCI-INTERMEDIATE BRANCH FINAL RESULT Promus 2.5x12mm, 2.25x15mm, 2,25x15mm

12/2009: recurrent chest pain!!! Severe stenosis of the intermediate branch within the stented segment, with stent strut fracture near the distal overlapping site.

E D C B A

12/2009 Significant hyperplasia and absence of the metallic stent struts corresponding to complete fracture of the distal stent.

FINAL RESULT 12/2009 Promus Element 2.25x16 mm

12/2009: PCI-Cx Promus Element 2.25x12mm Due to severe tortuosity of the proximal segment of the Cx, the Venture wire control catheter was used, in order to facilitate the passage of the guide-wire.

Venture™ Wire Control Catheter

12/2009: PCI-RCA RCA severely calcified with angulation at its proximal segment. Significant stenosis at the bifurcation with an acute marginal branch.

12/2009 Due to inability to advance a balloon, decision was made to rotablate. (RA burr size 1.5mm)

12/2009: PCI-RCA Promus Element 3.0x18mm Kissing balloon

12/2009: PCI-RCA FINAL RESULT

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

Coronary stent fracture is a rare but potentially serious complication The reported incidence of SF in different studies ranges between 0.8% and 7.7%, mainly due to variations - in the rates of angiographic follow-up - use of IVUS - definition of stent fracture and - differences in the types of stents used IVUS was more sensitive than fluoroscopy in detecting stent strut fractures in multiple studies Since IVUS evaluation is not routinely performed during follow-up, stent fracture is likely to be underdiagnosed

Factors predisposing to (drug-eluting) Stent Fracture Anatomic Procedural Stent design Cardiac motion Long stent Closed cell Vessel angulation Overlapping stent Right coronary artery High pressure Saphenous vein graft Overexpansion

The change in vessel angulation after stent implantation is also associated with the occurrence of SF. Stent placement often straightens out the vessel; however, the vessel continues to return to its original shape. The force to return the vessel to its original shape may be stronger if the change in vessel angulation after stent implantation is increased. Longer stents are subjected to higher radial forces compared to shorter ones, and they may be prone to fracture, especially when placed in tortuous vessels or calcified lesions.

Most studies reported overlapping stents as a significant risk factor for SF, with an average rate of over 60% associated with overlapping stented lesions The majority of stent fractures occurred within 10 mm from areas of increased rigidity caused by strut overlap.

The majority of DES fracture events have been reported in SESs The closed-cell design of SES may be more prone to fracture when sheer forces are beyond its flexibility. The closed-cell design of the Cypher stent is more rigid, resulting in more straightening of coronary vessels compared to the open cell Taxus design. However, it also must be taken into account that the Cypher stent is more radio-opaque and stent fracture may be easier to diagnose by angiography.

Stent fractures were more commonly reported in the RCA Stent fractures were more commonly reported in the RCA . The predisposition of the RCA for SF is possibly attributed to the vessel anatomy, due to the excessive tortuosity, angulation, or change of angulation after stent implantation. The next most common locations were the LAD, Cx, saphenous vein grafts and the left main stem.

Clinical Implications The complications observed with DES fracture include : in-stent restenosis and target lesion revascularization, stent thrombosis myocardial infarction and sudden death Patients may remain asymptomatic

While most of the stent fractures have been discovered during follow-up angiography six months or more post-implantation, SF cases have been reported from immediately after to several years after the index procedure The length of time that a vessel wall is exposed to fractured stent struts may be important and possibly determine clinical outcomes. An early fracture affects local drug delivery and can lead to focal neointimal hyperplasia. On the other hand, since significant restenosis was not observed in a significant number of fracture sites, it may be presumed that in these cases, stent strut fracture occurred long enough after implantation so that the drug effect was not compromised .

Management strategies The management of stent fractures remains controversial. If focal in-stent restenosis occurs, it seems reasonable to repeat percutaneous revascularisation with a short stent. With repeat stenting there is a possibility of recurrence of SF whereas, on the other hand, the effect of balloon angioplasty on disrupted DESs is unknown. The use of paclitaxel-eluting stents or other newly developed DESs might be an appropriate selection since their platform is more flexible.

In our case, it seems that the use of three, overlapping stents along with the presence of angulation and increased vessel movememt contributed to the fracture. Despite the fact that each of them had relatively short length, the fracture occurred very close to the distal overlapping site, at a point where there was a vessel angulation. Point of distal overlapping

A careful examination of the vessel anatomy, careful selection of the stent length and type and a proper deployment technique is required for special coronary situations in order to reduce the occurrence of this phenomenon.

www.e-cardio.gr ΕΥΧΑΡΙΣΤΩ!